1. Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewal
   Prahlad Parajuli et al, 2016, Oncotarget CrossRef
2. Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
   Tatiana A. Mishchenko et al, 2024, Frontiers in Immunology CrossRef
3. Interleukin-17 augments tumor necrosis factor α-mediated increase of hypoxia-inducible factor-1α and inhibits vasodilator-stimulated phosphoprotein expression to reduce the adhesion of breast cancer cells
   Kuang Changchun et al, 2017, Oncology Letters CrossRef
4. IL-17 Signaling in the Tumor Microenvironment
   R. M. Gorczynski, 2020, Tumor Microenvironment CrossRef
5. IL‑17A promotes CXCR2‑dependent angiogenesis in a mouse model of liver cancer
   Liguo Liu et al, 2019, Molecular Medicine Reports CrossRef
6. Treatment of novel IL17A inhibitor in glioblastoma implementing 3rd generation co-culture cell line and patient-derived tumor model
   Md Shamsuddin Sultan Khan et al, 2017, European Journal of Pharmacology CrossRef
7. Involvement of P2X7 receptor signaling on regulating the differentiation of Th17 cells and type II collagen-induced arthritis in mice
   Zhi-Dan Fan et al, 2016, Scientific Reports CrossRef
8. IL‐17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K/AKT signalling pathway
   Qianqian Zheng et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
9. Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type
   Joseph Fabre et al, 2016, International Journal of Molecular Sciences CrossRef
10. Interleukin‑17 promotes the development of cisplatin resistance in colorectal cancer
    Guolong Sui et al, 2018, Oncology Letters CrossRef
11. Tumstatin attenuates the promotion effect of IL-17 secreted by Th17 cells on the stemness maintenance of glioma cells
    Wei Yu et al, 2021, Pathology - Research and Practice CrossRef